Abstract
A case of necrotizing myopathy due to a short epsilon-aminocaproic acid (EACA) treatment in a 72 year-old patient with subarachnoid haemorrhage (SAH) is described. Pathogenetic hypotheses are discussed.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aminocaproates / adverse effects*
-
Aminocaproic Acid / adverse effects*
-
Aminocaproic Acid / therapeutic use
-
Biopsy
-
Female
-
Humans
-
Muscles / pathology
-
Muscular Diseases / chemically induced*
-
Necrosis
-
Subarachnoid Hemorrhage / drug therapy
Substances
-
Aminocaproates
-
Aminocaproic Acid